For years, physicians have been aware that patients carrying the apolipoprotein ꜫ4 (APOE ꜫ4) gene are at a greater risk of developing Alzheimer’s disease. New research from McGill University has now found the gene plays an even greater role in dementia.
Volume in brain region linked to physiological changes characteristic of AD
New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.
In the United Kingdom, "the number of adult men being admitted to hospital with an eating disorder has risen by 70% over the past six years – the same rate of increase as among women," reports The Guardian. Is there a similar trend in Canada?
To learn about the new and improved facilities of the Douglas Institute's brain bank, please visit the following link: http://montreal.ctvnews.ca/douglas-intitute-s-brain-bank-shows-off-new-facilities-1.2531409.
Imagine being able to easily get over all of the discomfort and problems of jet lag or night-shift work. Science is not quite there, but recent work by Marc Cuesta, Nicolas Cermakian and Diane B. Boivin from the Douglas Mental Health University Institute and McGill University has opened new therapeutic avenues for improving the synchronization of the body's different biological clocks.
By Cynthia Lee - News - June 8, 2014
Levels of a small molecule found only in humans and in other primates are lower in the brains of depressed individuals, according to researchers at McGill University and the Douglas Institute. This discovery may hold a key to improving treatment options for those who suffer from depression.
9,8 millions de dollars pour créer un centre spécialisé en recherche sur la dépression et le suicide
Mimi Israël, MD, and Serge Beaulieu, MD, PhD received a 2013 “Coup de chapeau verdunois” for their commitment as first-line psychiatrists. The awards were handed out by Roger Cadieux, President of the Forum économique de Verdun, during a recognition ceremony on the evening of November 27.
This award recognizes the involvement of Verdun residents and employees.
Salah El Mestikawy, PhD, a researcher at The Douglas Institute, along with his research team, have received $1.5 million to explore the dual signalling capacity of neurons. This research grant is one of five new Multi-Investigator Research Initiative (MIRI) grants awarded by Brain Canada with funds from the Canada Brain Research Fund and Partners. The Douglas team will work with colleagues at the University of Western Ontario.
Dr. Suzane Renaud, a clinical psychiatrist from Montreal, Quebec, who specializes in treating bipolar and personality disorders, was inaugurated as President of the Canadian Psychiatric Association.
Prior to joining the Douglas Institute where she has worked for the past five years an outpatient clinic, she worked in the Community Mental Health Centre at CHUM's Saint Luc Hospital for over 20 years, principally treating patients with psychotic illnesses. At CHUM she served as both interim Department Chief (2001) and as Service Chief (2004-2006) of General Psychiatry.